The trial will be conducted in the Democratic Republic of the Congo in partnership with Emergent BioSolutions.
Emergent BioSolutions' Q3 earnings report drives 20% surge in share price, reflecting market optimism. See why award a ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...